Usage: Depakote treats manic episodes in bipolar disorder, complex partial and absence seizures (as monotherapy or adjunctive therapy), and prevents migraine headaches. Not indicated for acute migraine treatment.
Usage: Depakote treats acute manic or mixed episodes in bipolar disorder, complex partial and absence seizures in adults and children 10+, and prevents migraine headaches. Not for acute migraine treatment. Use in women of childbearing potential is restricted due to fetal risk.
Usage: Emrelis treats adults with locally advanced or metastatic non-squamous NSCLC with high c-Met protein overexpression (≥50% of tumor cells, 3+ staining) who have received prior systemic therapy. Approved under accelerated approval based on overall response rate and duration of response.